ACT 335827 [1354039-86-3]

TargetMol Chemicals

ACT 335827 [1354039-86-3]

44

1354039-86-3

Research Use Only

ACT 335827

C31H38N2O5

518.64

ACT-335827 is an orally available, brain-penetrant, orexin type 1 receptor-selective antagonist, with IC50 values of 6 nM for OXR1 and 417 nM for OXR2. It is suitable for studies related to neurological disorders [1].

3 years

C([C@H]1C=2C(=CC(OC)=C(OC)C2)CCN1[C@@H](C(NC(C)C)=O)C3=CC=CC=C3)C4=CC(OC)=C(OC)C=C4

-20°C

12352200